rs150236752
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_001370466.1(NOD2):āc.1888A>Gā(p.Ser630Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,609,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001370466.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOD2 | NM_001370466.1 | c.1888A>G | p.Ser630Gly | missense_variant | 4/12 | ENST00000647318.2 | NP_001357395.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOD2 | ENST00000647318.2 | c.1888A>G | p.Ser630Gly | missense_variant | 4/12 | NM_001370466.1 | ENSP00000495993.1 | |||
NOD2 | ENST00000300589.6 | c.1969A>G | p.Ser657Gly | missense_variant | 4/12 | 1 | ENSP00000300589.2 | |||
NOD2 | ENST00000641284.2 | n.1888A>G | non_coding_transcript_exon_variant | 4/6 | ENSP00000493088.1 | |||||
NOD2 | ENST00000646677.2 | n.1888A>G | non_coding_transcript_exon_variant | 4/13 | ENSP00000496533.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250364Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135352
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1457392Hom.: 0 Cov.: 34 AF XY: 0.0000138 AC XY: 10AN XY: 724064
GnomAD4 genome AF: 0.000112 AC: 17AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74392
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Regional enteritis;C5201146:Blau syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at